Regional Health Properties, Inc. (RHEP)
OTCMKTS
· Delayed Price · Currency is USD
2.530
+0.430 (20.48%)
Jun 18, 2025, 3:56 PM EDT
RHEP Revenue
Regional Health Properties had revenue of $7.12M in the quarter ending March 31, 2025, with 73.70% growth. This brings the company's revenue in the last twelve months to $20.69M, up 27.52% year-over-year. In the year 2024, Regional Health Properties had annual revenue of $17.67M with 10.32% growth.
Revenue (ttm)
20.69M
Revenue Growth
+27.52%
P/S Ratio
0.21
Revenue / Employee
80.81K
Employees
256
Market Cap
4.32M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 17.67M | 1.65M | 10.32% |
Dec 31, 2023 | 16.01M | -15.00M | -48.36% |
Dec 31, 2022 | 31.01M | 4.50M | 16.98% |
Dec 31, 2021 | 26.51M | 9.85M | 59.17% |
Dec 31, 2020 | 16.65M | -3.76M | -18.42% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo, Inc. | 1.73B |
Veradigm | 588.02M |
Elite Pharmaceuticals | 70.00M |
Tian'an Technology Group | 1.78M |
Northwest Biotherapeutics | 1.47M |
Glass House Brands | 215.62M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.70M |